The Role of Zinc Finger Genes in Leukemogenesis
锌指基因在白血病发生中的作用
基本信息
- 批准号:8490414
- 负责人:
- 金额:$ 35.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdult LymphomaAmino AcidsBindingBiochemicalBiologicalBiological ProcessCD8B1 geneCell Cycle ProgressionCell Cycle RegulationCell ProliferationCell physiologyCellsChildhoodChildhood Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaDNA BindingDataDevelopmentDown-RegulationExhibitsFunctional disorderG1 PhaseGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGoalsHematopoieticHumanIkaros proteinImmuneIn VitroInfantInterleukin-2Knockout MiceLymphomaMalignant - descriptorMalignant NeoplasmsMapsMolecularMusNucleic Acid Regulatory SequencesPatientsPeripheralPhosphorylationPhosphorylation SitePhosphotransferasesProcessProtein DephosphorylationProteinsRNA InterferenceRNA SplicingRegulationRegulatory ElementResearchRetroviral VectorRoleS PhaseSignal TransductionSignal Transduction PathwaySiteStem cellsSystemT cell differentiationT-Cell ProliferationT-LymphocyteTestingTranscriptional RegulationTransplantationTumor Suppressor ProteinsUp-RegulationZinc Fingersadult leukemiabone marrow hyperplasiachromatin remodelingeffective therapyin vivoinsightleukemialeukemia/lymphomaleukemogenesismouse modelmutantnoveloverexpressionpromoterprotein protein interactionreconstitutionresearch studyresponsethymocyte
项目摘要
PROJECT SUMMARY
The objective of the proposed study is to understand the malignant transformation of hematopoietic cells
by identifying the biological functions of Ikaros proteins. Ikaros is essential for hematopoietic development and
acts as a tumor suppressor. The Ikaros gene is alternately spliced to generate multiple zinc finger proteins
involved in gene regulation and chromatin remodeling.
Our preliminary data show that: 1) Ikaros is phosphorylated at multiple evolutionarily conserved sites by
CK2 and other kinases during G1 and S phase of the cell cycle 2) Phosphorylation of Ikaros at specific amino
acids regulates its DNA-binding ability and subcellular localization. 3) Ikaros binds to the Bcl-xL gene promoter
in vivo and disregulation of Ikaros activity is associated with upregulation of Bcl-xL gene expression.
The specific aims of our proposals are: Specific Aim #1: To identify the specific phosphorylation sites
responsible for Ikaros function in the regulation of transcription, cellular proliferation and differentiation. We
hypothesize that phosphorylation of Ikaros interferes with its function in transcriptional regulation and
chromatin remodeling and influences cellular proliferation. We will define phosphorylation sites that are critical
for Ikaros function in DNA-binding, subcellular localization, and protein-protein interaction. The role of Ikaros
phosphorylation in controlling cell cycle progression will be studied using a murine leukemia cellular system
derived from Ikaros deficient mice. These cells will be transduced with wild type or Ikaros phosphomimetic
mutants to define sites that are critical for Ikaros' function in cell cycle control. The role of Ikaros'
phosphorylation in regulating T cell differentiation and T cell proliferation will be studied in vivo. Murine stem
cells from mice with targeted disruption of Ikaros will be infected with retroviral vectors containing wild type
Ikaros or phosphomimetic Ikaros mutants and transplanted into sublethally irradiated Ikaros knockout mice.
The ability of phosphomimetic Ikaros mutants to restore normal T cell differentiation will be compared to that of
wild type Ikaros. Specific aim #2: To dissect the mechanism by which Ikaros regulates Bcl-xL expression.
Previous studies suggest that decreased Ikaros activity leads to overexpression of the Bcl-xL gene. We
hypothesize that Ikaros exerts its tumor suppressor activity by negatively regulating Bcl-xL expression. To test
this hypothesis we will determine whether increased Ikaros expression downregulates Bcl-xL transcription in
human lymphoma cells and we will map the regions of the Bcl-xL upstream regulatory element (URE) that are
critical for Ikaros-modulated control of Bcl-xL expression.
These studies will provide the first detailed functional analysis of the signal transduction pathways that
control the tumor suppressor function of Ikaros. Our research will provide new and important information on the
mechanisms controlling the proliferation of hematopoietic cells and will yield insights into the pathophysiology
and treatment of leukemia.
项目概要
拟议研究的目的是了解造血细胞的恶性转化
通过鉴定 Ikaros 蛋白的生物学功能。 Ikaros 对于造血发育至关重要
作为肿瘤抑制剂。 Ikaros基因交替剪接生成多种锌指蛋白
参与基因调控和染色质重塑。
我们的初步数据表明:1) Ikaros 在多个进化保守位点被磷酸化
细胞周期 G1 和 S 期的 CK2 和其他激酶 2) Ikaros 在特定氨基处的磷酸化
酸调节其 DNA 结合能力和亚细胞定位。 3) Ikaros结合Bcl-xL基因启动子
Ikaros 活性的失调与 Bcl-xL 基因表达的上调有关。
我们提案的具体目标是: 具体目标#1:确定特定的磷酸化位点
负责 Ikaros 调节转录、细胞增殖和分化的功能。我们
假设 Ikaros 的磷酸化会干扰其转录调控功能
染色质重塑并影响细胞增殖。我们将定义关键的磷酸化位点
Ikaros 在 DNA 结合、亚细胞定位和蛋白质-蛋白质相互作用中发挥作用。伊卡洛斯角色
将使用鼠白血病细胞系统研究控制细胞周期进程的磷酸化
源自 Ikaros 缺陷小鼠。这些细胞将用野生型或 Ikaros 磷模拟物转导
突变体来定义对 Ikaros 在细胞周期控制中的功能至关重要的位点。伊卡洛斯的角色
将在体内研究调节 T 细胞分化和 T 细胞增殖的磷酸化。鼠干
来自靶向破坏 Ikaros 的小鼠的细胞将被含有野生型的逆转录病毒载体感染
Ikaros 或拟磷 Ikaros 突变体并移植到亚致死照射的 Ikaros 基因敲除小鼠中。
拟磷化 Ikaros 突变体恢复正常 T 细胞分化的能力将与
野生型伊卡洛斯。具体目标#2:剖析 Ikaros 调节 Bcl-xL 表达的机制。
先前的研究表明,Ikaros 活性降低会导致 Bcl-xL 基因过度表达。我们
假设 Ikaros 通过负向调节 Bcl-xL 表达来发挥其肿瘤抑制活性。测试
根据这一假设,我们将确定 Ikaros 表达增加是否会下调 Bcl-xL 转录
人类淋巴瘤细胞,我们将绘制 Bcl-xL 上游调节元件 (URE) 的区域,这些区域是
对于 Ikaros 调节的 Bcl-xL 表达控制至关重要。
这些研究将对信号转导途径进行首次详细的功能分析,
控制Ikaros的抑癌功能。我们的研究将提供有关以下方面的新的重要信息
控制造血细胞增殖的机制并将深入了解病理生理学
和治疗白血病。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
AMID mediates adenosine-induced caspase-independent HuH-7 cell apoptosis.
AMID 介导腺苷诱导的不依赖 caspase 的 HuH-7 细胞凋亡。
- DOI:
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Yang, Dongqin;Yaguchi, Takahiro;Nagata, Tetsu;Gotoh, Akinobu;Dovat, Sinisa;Song, Chunhua;Nishizaki, Tomoyuki
- 通讯作者:Nishizaki, Tomoyuki
Induction of senescence by adenosine suppressing the growth of lung cancer cells.
腺苷诱导衰老抑制肺癌细胞的生长。
- DOI:10.1016/j.bbrc.2013.09.030
- 发表时间:2013-10-11
- 期刊:
- 影响因子:3.1
- 作者:Dongqin Yang;Junyao Song;Lijun Wu;Yunfang Ma;Chunhua Song;S. Dovat;T. Nishizaki;Jie Liu
- 通讯作者:Jie Liu
Ikaros isoforms: The saga continues.
Ikaros 同种型:传奇仍在继续。
- DOI:
- 发表时间:2011-06-26
- 期刊:
- 影响因子:0
- 作者:Li, Zhanjun;Perez;Savic, Aleksandar;Song, Chunhua;Dovat, Sinisa
- 通讯作者:Dovat, Sinisa
Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
B 细胞急性淋巴细胞白血病中 Ikaros、组蛋白脱乙酰酶 1 (HDAC1) 和酪蛋白激酶 2 (CK2) 对 JARID1B/KDM5B 组蛋白脱甲基酶的转录调节。
- DOI:
- 发表时间:2016-02-19
- 期刊:
- 影响因子:0
- 作者:Wang, Haijun;Song, Chunhua;Ding, Yali;Pan, Xiaokang;Ge, Zheng;Tan, Bi;Gowda, Chandrika;Sachdev, Mansi;Muthusami, Sunil;Ouyang, Hongsheng;Lai, Liangxue;Francis, Olivia L;Morris, Christopher L;Abdel;Dorsam, Glenn;Xiang, Meixi
- 通讯作者:Xiang, Meixi
Genetic targets in pediatric acute lymphoblastic leukemia.
小儿急性淋巴细胞白血病的遗传靶点。
- DOI:
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Gowda, Chandrika;Dovat, Sinisa
- 通讯作者:Dovat, Sinisa
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sinisa Dovat其他文献
Sinisa Dovat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sinisa Dovat', 18)}}的其他基金
Novel targeted therapy to reduce health disparities in pediatric leukemia
减少儿童白血病健康差异的新型靶向治疗
- 批准号:
10608229 - 财政年份:2023
- 资助金额:
$ 35.97万 - 项目类别:
Targeting CK2 oncogenic pathway to overcome drug resistance in high-risk leukemia
靶向CK2致癌途径克服高危白血病耐药性
- 批准号:
10160808 - 财政年份:2017
- 资助金额:
$ 35.97万 - 项目类别:
Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia
以 CRLF2 和 Ikaros 改变为目标,减少儿童白血病的健康差异
- 批准号:
9753178 - 财政年份:2016
- 资助金额:
$ 35.97万 - 项目类别:
Targeting CRLF2 and Ikaros Alterations to Reduce Health Disparities in Childhood Leukemia
以 CRLF2 和 Ikaros 改变为目标,减少儿童白血病的健康差异
- 批准号:
9302326 - 财政年份:2016
- 资助金额:
$ 35.97万 - 项目类别:
The Role of Zinc Finger Genes in Leukemogenesis
锌指基因在白血病发生中的作用
- 批准号:
7851194 - 财政年份:2009
- 资助金额:
$ 35.97万 - 项目类别:
The Role of Zinc Finger Genes in Leukemogenesis
锌指基因在白血病发生中的作用
- 批准号:
7851194 - 财政年份:2009
- 资助金额:
$ 35.97万 - 项目类别:
The Role of Zinc Finger Genes in Leukemogenesis
锌指基因在白血病发生中的作用
- 批准号:
8254521 - 财政年份:2009
- 资助金额:
$ 35.97万 - 项目类别:
The Role of Zinc Finger Genes in Leukemogenesis
锌指基因在白血病发生中的作用
- 批准号:
7663490 - 财政年份:2009
- 资助金额:
$ 35.97万 - 项目类别:
The Role of Zinc Finger Genes in Leukemogenesis
锌指基因在白血病发生中的作用
- 批准号:
8231832 - 财政年份:2009
- 资助金额:
$ 35.97万 - 项目类别:
The Role of Zinc Finger Genes in Leukemogenesis
锌指基因在白血病发生中的作用
- 批准号:
8296355 - 财政年份:2009
- 资助金额:
$ 35.97万 - 项目类别:
相似海外基金
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10889325 - 财政年份:2023
- 资助金额:
$ 35.97万 - 项目类别:
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10589798 - 财政年份:2022
- 资助金额:
$ 35.97万 - 项目类别:
Exploiting Metabolism to Uncloak Epstein-Barr Virus Immunogens in Latently Infected B-cells
利用代谢揭示潜伏感染 B 细胞中的 Epstein-Barr 病毒免疫原
- 批准号:
10449547 - 财政年份:2022
- 资助金额:
$ 35.97万 - 项目类别:
Roles of p53-Regulated Pro-Survival Signals in Carcinogenesis by HTLV-1 and High-Risk Subtype HPVs
p53 调节的促生存信号在 HTLV-1 和高危亚型 HPV 致癌过程中的作用
- 批准号:
10572142 - 财政年份:2022
- 资助金额:
$ 35.97万 - 项目类别:
Immunologic control of HIV-1 through combination bNAbs and biologics.
通过 bNAb 和生物制剂的组合对 HIV-1 进行免疫控制。
- 批准号:
9804264 - 财政年份:2019
- 资助金额:
$ 35.97万 - 项目类别: